Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Ginkgo Bioworks (DNA) declined 7.57% in recent trading, significantly underperforming the broader market. The stock has gained 78.82% over the past month but faces headwinds with projected earnings of -$0.58 per share and a 47.22% revenue decline expected. The company holds a Zacks Rank of #3 (Hold), with its industry ranking in the bottom 28% of all sectors.